K. Peony Yu
Overview
K. Peony Yu received an average of $3M in total compensation, including $503K in salary, at FibroGen from 2013 to 2020.
Source: SEC filings on April 13, 2021, April 23, 2020, April 23, 2019, April 24, 2018, April 24, 2017, and April 22, 2016.
Related executives
We found ten more executives who work or worked at FibroGen.
Enrique Conterno
FibroGen
Chief Executive Officer
Christine Chung
FibroGen
Senior Vice President, China Operations
Mark Eisner
FibroGen
Chief Medical Officer
Pat Cotroneo
FibroGen
Chief Financial Officer
Elias Kouchakji
FibroGen
Senior Vice President, Clinical Development, Drug Safety, and Pharmacovigilance
Thane Wettig
FibroGen
Chief Commercial Officer
Juan Graham
FibroGen
Chief Financial Officer
James Schoeneck
FibroGen